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1. Introduction
There is an extensive literature on hospital cost functions for
industrialized countries, but a much smaller literature for developing
co:  'tries.1  Yet the issues facing policy-makers in both sets of
cot .tries  are much the same:  Are hospitals over-capitalized, as is
often claimed of US hospitals?  Are hospitals inefficient in other
respects?  Do hospitals vary in their degree of inefficiency?  Are
private hospitals more efficient than their public counterparts?  Should
hospitals specialize or provide a broad range of services?  Could costs
be reduced by concentrating cases in fewer hospitals?  Such issues are
as relevant to policy-makers in developing countries as to their
counterparts in the industrialized world.
Moreover, it seems likely that the econometric techniques that
have been used to such effect in the industrialized world would be
equally capable of informing policy debate in the developing world.  Our
purpose in this paper is to provide a survey of these techniques and to
summarize the work to date on developing countries.  Though the paper is
written primarily with developing countries in mind, it is hoped that it
may be of some value to researchers in industrialized countries.  Our
survey of econometric techniques is not uncritical.  We question, for
example, the validity of recent tests of over-capitalization undertaken
on American hospitals.  We also make various general observations about
the methods used to investigate economies of scope and economies of
scale.
Section 2 provides a survey of the issues facing policy-makers in
the hospital sector and the relevant econometric techniques.  sections 3
to 6 contain surveys of four recent studies of hospital costs in Kenya,
Peru, Ethiopia and Nigeria.  The final section contains our conclusions
concerning both the studies undertaken to date and the methods for
analyzing hospital costs.
2.  Some economics and econometrics of hospitals
As indicated above, there are, broadly-speaking, four sets of
policy issues that can be addressed using cost function analysis: (i)
are hospitals over-capitalized?,  (ii)  are hospitals inefficient?, (iii)
should hospitals specialize or provide a broad range of services?, and
(iv) are there too many hospitals?
2.1 Are hosoitals over-canLtalized?
The issue is whether hospitals have a capital stock that is too
large given their output level.  In developed countries - especially the
United States - it is often argued that this is the case, the
'.  For  reviews  of  the  American  and  British  literature  see  Cowing,  Noltmann  and  Peters  (1983)  and  Wagstaff
(1989a).  Several  of  the  more  recent  studies  for  industriaLized  countries  are  referred  to  in  the  present  paper.
To  our  knowledge  there  has  been  no  survey  of  developing  country  studies.2
implication  being  that  hospitals  ought  to reduce  their  capital  stock.
It is important  to realize  that  the issue  of over-capitalization  is
different  from  the issue  of economies  of scale. The latter  concerns  the
effect  on costs  of further  expansion  of output  and  therefore  bears  on
the  question  of whether  output  levels  are  too  high  or too low.  Authors
of many  early  cost function  studies  confused  the  two issues. Writers
such  as Feldstein  (1967)  and  Anderson  (1980),  for  example,  claim  to
address  the issue  of economies  of scale,  but in  the  event  analyzed
over-capitalization  .2
The  currently  favored  approach  to over-capitalization  dates  back
to Cowing  and  Holtmann  (1983),  who  proposed  analyzing  the issue  by
reference  to the  parameters  of the  variable  cost  function. In  the
short-run,  when  the  capital  stock  is fixed,  short-run  costs,  CS, can  be
written  as the  sum  of total  fixed  costs  and  total  variable  costs
(1)  Cs =  F  +  Cv(Y WV,K)  ,
where  F=wKK  is total  outlay  on the fixed  input,  y is output,  wv is  the
price(s)  of  the variable  input(s)  and  K is  the stock  of capital. It is
worth  noting  that K enters  CS twice:  once  as a determinant  of fixed
costs  and  once as a determinant  of variable  costs  - an issue  to which  we
return  below. The long-run  cost-minimizing  capital  stock,  K*,  is  that
which  minimizes  costs  at each  level  of output. Differentiating  (1)  with
respect  to K and setting  the  derivative  equal  to zero  yields
(2)  -wK  =  6Cv/6K.
To  test for  over-capitalization  Cowing  and  Holtmann  suggest  estimating
the variable  cost  equation  Cv(y,wv,K)  and  testing  the  hypothesis  that
6Cv/6K=-wK.
The  intuition  here can  be illustrated  with fig  1, which  shows
three  possible  input  mixes  to produce  a single  output  y.  Without  loss
of generality  set  wK  equal  to 1.  Then  the  vertical  intercept  of each
isocost  line  is equal  to Cs,  the  value  of K is equal  to F and  the
vertical  distance  between  Cs  and F is  equal  to Cv. The long-run  optimal
stock  of capital  is K.  At point '1',  the capital  stock  is  too small
and  a move from  point '1'  towards  point '2'  would  cause  total  cost  to
fall.  (Fixed  costs  would  rise,  but  this  rise  would  be more than  offset
by a fall in  variable  costs.) Hence  at point '1'  6Cv/6K<-wK.  At point
'3',  by contrast,  the capital  stock  is  too large  and  a reduction  in
capital  towards  K would  reduce  total  cost.  (Variable  costs  would  rise,
but this  would  be more than  offset  by the  reduction  in fixed  costs.)
Hence  at point '3'  6Cv/ 6K>-wK. Only  at point '2',  where  the cap:tal
stock  is  at  its  long-run  equilibrium  value,  is  6Cv/5K  equal  to  -wK.
2.  That  the  approach  used  by  Feldstein  is  itt-suited  to  the  analysis  of  economies  of  scale was  argued long
ago  by Davis  (1968)  and  Mann  and  Yett  (1968).  That  his  approach  is  better  suited  to the  analysis  of
over-capitaLization  has  not,  to  our  knowledge,  been  argued  before.3
In Cowing and Holtmann's
study,  as in most cost  function  K
studies  in which  a  proxy  for  ')\
capital stock is included among  3
the  regressors,  the  derivative  F 
of cost  with respect  to capital
is  positive. Cowing  and
Holtmann  interpret  this  as
evidence  of
over-capitalization.  However,  2  2
this interpretation  is,  in  K  .\  .......  .
fact,  inconsistent  with  F'  I  c  . -
economic  theory. An increase  Yo
in capital  ought  always  to  v
reduce  variable  costs,  because
usage  of variable  inputs  must  Figure  I
decline  if output  is  to remain
unchanged. Hence  6Cv/6K  ought
always  to be negative. That
the  derivative  of cost  with  respect  to capital  is positive  in such
studies  suggests  that  the  dependent  variable  may not  actually  be
variable  costs,  but  may instead  include  some  fixed  costs.  If,  for
example,  all fixed  costs  are included  in  the cost  variable,  a positive
6Cs/6K  makes  perfect  sense;  indeed  this  is precisely  the  condition  for
over-capitalization.
This  suggests  an
alternative  testing  strategy,
which  addresses  the fact  that
it  will  typically  be difficult  cs
to purge  cost  data  of fixed
costs: estimate a short-run  C  CY,  WV  K)
total  cost  equation  and  test
the  hypothesis  that 6Cs/6K=O.  ......
This  is similar  to the  approach  Cs
adopted  long  ago  by Feldstein  '
(1967),  though  he confusingly  c2 ............
argued  that  he was
investigating  economies  of  K'  K3  K
scale  rather  than
over-capitalization.  From  fig  _
1 it is evident  that the  Figure  2
partial  relationship  between
short-run  total (and  average)
cost  and capital  stock  is
U-shaped  (fig  2).  Moving  along  this curve  is equivalent  to moving  from
one  short-run  average  cost  curve  to another  (fig  3).  At point '1'
6C 5/6K<O  (and,  by implication,  6CV/ 6K<-wK),  while  at point '3'  6Cs/6K>O
(and,  by implication,  6Cv/ 6K>-wK). Hence  if one  estimates  a short-run
total (or  average)  cost  function  and  finds  that  a hospital  is operating
to the  right  of the  minimum  point  of the  partial  relationship  between4
cost and capital stock, one can conclude that the hospital is
over-capitalized.
Theory suggests various
restrictions that need to be  c
placed  on  a  short-run  cost
function  and  it  is  worth*
spelling these out.  First, the  C5
equation could be additive in  cL5
fixed and variable costs.  If,  \
C
as is often the case, the
shadow price of capital is  c
unknown, the fixed cost
component of the equation ought
not to contain an intercept and
instead  capital  ought  to  be
entered  as  a  regressor;  its
coefficient would then be  Q  -
interpreted as the shadow price  Fiure3
of capital.  Second, assuming
convexity of isoquants, total
variable costs ought to be
decreasing in capital stock with the derivative approaching zero
asymptotically.  In other words, as substitution of labor for capital
gets harder and harder, an ever increasing share of the extra cost
associated with increases in capital stock will be taken up by extra
fixed costs.  The partial relationship between short-run total cost and
capital stock ought, as indicated above, to be U-shaped.
2.2 Are hbositals inefficient?
A distinction is normally made between technical inefficiency
(failing to produce the maximum possible output from a given bundle of
inputs) and allocative inefficiency (employing inputs in the wrong
proportions given their prices and productivity at the margin).  The
issue of over-capitalization examined above is, of course, one aspect of
allocative efficiency.  In principle both types of inefficiency might be
present in the hospital sector and  it is useful for policy-makers to
know the extent of any such inefficiency in the hospital sector as a
whole, as well as any variation across hospitals.  It is also of
interest, of course, to know whether there is any variation between one
sub-sector (eg  the private sector) and another (eg  the public sector).
Technical efficiency can be analyzed using either non-statistical
approaches 3,  such as data envelopment analysis, or statistical methods,
3.  For  an  example  of  the  non-statistical  approach  in  the  context  of  the  hospitaL  sector  see  Grosskopf  and
Valdmanis  (1988).4
such  as the frontier  production  function 4. We focus  here  on the latter.
Suppose  for  simplicity  that  the  production  function  is
Cobb-Douglas:
(3) lny,  =  00  +  Ejpjlnxu  +  ui
where  y is  output,  the  xj are inputs,  the P's  are  output  elasticities
and  u is an error  term.  Feldstein  (1967)  suggested  that the  residuals
of eq (3)  might  be used  as estimates  of technical  inefficiency,  so that
a hospital  with a zero  residual  is said  to be of average  technical
inefficiency,  while  a hospital  with a positive  (negative)  residual  is
said  to be of above-average  (below-average)  technical  efficiency. 5 A
disadvantage  of this approach  is  that it  provides  no information  on the
level  of efficiency. Clearly,  it is important  to know  whether
inefficient  hospitals  are  very inefficient  or only  marginally  so.  This
defect  can  be overcome  using  the  deterministic  frontier  model (DFM)  of
Aigner  and  Chu (1968),  which  differs  from  eq (3)  in that it constrains
the  error  term  to be non-positive. Hospitals  can  thus operate  on or
below  the  production  frontier  but  not  above  it,  and  the extent  of
technical  inefficiency  is indicated  by the  estimated  residuals,  u1. The
DFM can  be estimated  using  a  variety  of methods,  the simplest  of which
is  Corrected  Ordinary  Least  Squares: this involves  shifting  up the  OLS
estimate  of the intercept  until  one  residual  is  zero  and all  the  rest
are  negative. 6
There  is,  however,  a second  problem  with Feldstein's  approach,
which is  not  overcome  by the  DFM,  namely  that  it implicitly  assumes  that
all  cross-sample  variation  in  the  error  term of the  estimating  equation
is  due to variation  in efficiency. In  reality  the  residuals  are also
likely  to reflect  random  influences  outaide  the hospital's  control,  as
well as statistical  'noise'. A better  tool is the  stochastic  frontier
model (SFM)  [cf  eg Aigner  et al. (1977)]:
(4) lny;  =  00+ EjAjlnx 1 j  +  vj+  ui  uiS0,
so that the  error  term  vj+u 1 is  composed  of  two  parts,  v;  being  two-sided
and capturing  random  shocks  and  statistical  noise,  and  ui  being
one-sided  and  reflecting  inefficiency,  which  is  constrained  to be
4.  For  surveys  of  parametric  and  non-parametric  approaches  to  efficiency  measurement  see  Schmidt  (1986)
and  Barrow  and  Wagstaff  (1989).
5.  The  rationale  behind  this  is  that  the  output  of  a  hospital  with  a  residual  equal  to  zero  is  exactly  the
output  that  wouLd  be  expected  of  It  given  its  input  utilization  and  the  average  estimated  productivity  of  the
inputs.  By  contrast,  a  hospitaL  with  a  positive  (negative)  residual  produces  more  (Less)  than  it  would  have  been
expected  to  produce  on  the  basis  of  its  input  usage  and  the  estimated  parameters  of  the  production  function.
. Cf.  Forsund,  Lovelt  and  Schmidt  (1980)  and  Schmidt  (1986).6
non-positive.  Inefficiency is measured relative to the stochastic
frontier (po+Ejpjx+vi).  There are, broadly-speaking, two approaches to
estimation of the SFM.  One involves m&king an assumption about the
distribution of the ul  in a cross-section, the most common assumption
being that the u;  are half-normal.  The model can then be estimated by
supplementing the information normally used in the estimation of the
regression model with information on the extent of skewness in the
residuals (see Schmidt and Lovell (1979)].7 One then ends up with a
residual for each hospital, an estimate of the mean of the u 1, but not
an estimate of ul. What one can estimate, however, is E(u 1jv 1+u,)  - the
expected value of u,,  given the value of the composite error (see
Jondrow et al. (1982)).  The alternative estimation approach involves
the use of panel data and assumes that inefficiency remains constant
over time (cf  Schmidt and Sickles (1984)].  By working with data in
terms of deviations from temporal means, one can eliminate the
unobservable inefficiency term, which can then be recovered once the
parameters of the production function have been estimated.
The detection of allocative inefficiency is, in principle at
least, relatively straightforward.  Allocative efficiency requires that
for each pair of inputs j  and m
(5)  ZP/MP/  = wi/wl
where MPj  is the marginal product of the jth input and wj  is its price.
In the case of the Cobb-Douglas production function this condition
becomes
(6)  pj/l.  =  wjxj/w,xm,
i.e., the ratio of expenditures on the two inputs equals the ratio of
their output elasticities.  Because the , are invariant with respect to
the amount of each of the inputs employed, the left-hand side of eq (6)
can be treated as a datum.  Any discrepancy between the ratio of output
elasticities and the expenditure ratio is therefore to be attributed to
incorrect usage of one or both of the inputs.  Once one has estimates of
the P,,  one can determine whether one input is over- or under-employed
relative to another.  If, for example, the right-hand side of (6) is
larger than the left-hand side, the kth input is being over-employed
relative to the jth.  For other functional forms - such as the translog
- allocative efficiency can be assessed by comparing the ratio of
marginal products with the ratio of input prices. 8
7.  An  alternative  to  this  so-called  moments  estimator  is  a  maximum  Likelihood  (ML)  estimator  (see  eg  Greene
(1980,  1982)1.
8,  The  standard  shares  equation  approach  in  this  context  is  cLearly  inappropriate,  since  it  assumes  that
the  residuals  of  the  shares  equations  have  zero  mean  [cf  Wagstaff  (1989b)1.7
One possible way of measuring allocative inefficiency is to
calculate by how much a hospital's output would increase if it optimally
reallocated its budget and use the ratio of actual output to feasible
output ae the measure of allocative inefficiency (cf Feldstein (1967)).
Alternatively, in the two-input case, one might employ the index
proposed by Goldman and Grossman (1983):
(7)  Ali  =(MPH/MP  ) (w2/w,)-  |,
which in the case of the Cobb-Douglas becomes
(7')  AI =  I(P 1/P2).(w2x2i/w 1x1)-l-
Allocative efficiency gives a zero value of AI, while allocative
inefficiency results in AI being positive.
The effect of both technical and allocative inefficiency is, of
course, to raise a hospital's costs above their feasible minimum.  It is
instructive, therefore, to consider the relationship between a
hospital's production function and its cost function in the presence of
such inefficiency, not least because doing so ought to help establish
how the estimation of cost functions might shed light on the issue of
efficiency.  Consider the case of the Cobb-Douglas production function
(4).  If hospitals are technically and allocatively efficient, so that
the u 1 in eq (4) are zero for all hospitals, the associated cost
function takes the form
(8) lnC;  =  M +  (1/r)lny 1 +  (1/r)Ejpjlnpji  - (1/r)vj,
where r=E 1Pjdenotes  returns to scale (RTS) and M is a function of the
parameters of the cost function. 9 Suppose now that hospitals are both
technically inefficient and allocatively inefficient.  Thus ui<O  for
some i and instead of eq (6)  we have
(9) lnp,x,,  - lnpmx. +  ln(./pl) =  Sw  m=2,...,J.
Thus 6,,  represents the amount by which the mth first-order condition
for allocative efficiency fails to hold in the ith hospital.  Schmidt
and Lovell (1979) show that this gives rise to a cost function of the
form
(8') lnCi  =  M +  (l/r)lnyi  +  (1/r)Ejpjlnpji  - (1/r)fvi-u 1] +  (Ei-lnr),
where
E;= Zj(p/r)6J,  +  ln[Pj+Ej.¢xp(-6j)].
. N  is,  in  fact,  given  by
M  =  lnr  - 01/r) 0o  - (0/r)tnCf,0,0l
(see  eg  Schmidt  and  LoveLl  (1979,  p347)3.8
Thus, in the case of the Cobb-Douglas technology, technical and
allocative inefficiency leave the shape of the cost function unaffected,
but give rise to two non-negative hospital-specific effects,  (1/r)u 1 and
(Er-lnr),  the values of which indicate the percentage by which the ith
hospital's costs exceed their feasible minimum due to technical and
allocative inefficiency respectively.
Various points emerge from the above.  First, it suggests
alternative measures of technical and allocative inefficiency, namely
(l/r)u 1 and (Erlnr).  Second, it is clear that one cannot obtain
separate estimates of technical and allocative inefficiency by
estimating only a cost function; information from the production
function or the first-order cost-minimization conditions (9) is also
required.  By contrast, separate estimates of technical and allocative
inefficiency can be obtained by estimating only the production frontier,
since this provides all the information required to compute the two
inefficiency indices (l/r)u,  and (E,-lnr). Third, if one is content
merely to have an estimate of technical and allocative inefficiency
combined, estimation of a cost function would suffice.  But note that
since both types of inefficiency increase costs ((l/r)u 1 and (Erlnr) are
both non-negative), the appropriate model is a cost frontier which
explicitll takes into account this fact."' Including in one's cost
function variables other than input prices and output in an attempt to
capture inefficiency [of  eg Breyer (1987)] is a less reliable strategy.
2.3  Should hospitals specialize?
Another important issue confrontinq policy-makers is whether
hospitals should be encouraged to specialize or to provide a broad range
of services.  Should hospitals, for example, provide both inpatient and
outpatient care?  Should hospitals providing inpatient services aim to
treat most casetypes, or should they specialize?
Analysis of this issue dates back to Evans and Walker (1972),  who
employed informacion theory to derive an index of inpatient
specialization, which they then included in their cost function for
Canadian hospitals.  Their index involved a comparison between a
hospital's overall share of cases casemix proportions and the province's
proportions, with the index increasing in the degree of divergence
between a hospital's actual casemix proportions and the province's
proportions.  Thus a small hospital that is unable to treat the full
range of inpatient casetypes would typically have a high specialization
index.  Evans and Walker found that larger hospitals tended to be less
specialized (though  the correlation was fairly low) and that, holding
constant the stock of beds, casemix, length of stay, occupancy rate,
1O.  See  Wagstaff  (1989c)  for  an  empiricat  comparison  of  various  cost  frontier  models  estimated  on  a  sample
of  Spanish  hospitals.9
caseflow and outpatient expenditures, a high degree of specialization
raised average costs."
More recent work on specialization and hospital costs [cf  eg
Cowing and Holtmann (1983), Grannemann, Brown and Pauly (1986),  Vita
(1990)]  has built on the literature on economies of scope that emerged
in the 1980s lcf  eg Baumol, Panzar and Willig (1982)].  Economies of
scope are said to exist if the joint output of a single organization is
greater than the output that could be achieved by several separate
organizations each producing one product but together employing the same
amount of input.  In this context, inpatient and outpatient care might
be treated as two different products, and one might treat different
inpatient casetypes as different products.  An implication of economies
of scope is that production costs can be reduced by producing products
jointly, rather than specializing.  Thus in the two-product case (the
generalization to three or more products is straightforward), economies
of scope can be measured as
Sc =  (C(Y,,O)+C(O,Y 2 )-C(YI*Y 2)  )/C(YI,Y 2 )I
where C(y,-,0)  and C(O,y 2;) are the costs that would be incurred if y,*
units of y,  and y; units of y 2 were produced separately, and C(y*,y 2)  is
the cost that would be incurred if the same quantities of y,  and Y2 were
to be produced jointly.  With economies of scope, the joint cost is less
than the sum of the individual costs, so that Sc>O.  With diseconomies
of scope, Sc<O.  If both products have positive marginal costs, it can
be shown that Sc<l.
In order to establish whether economies of scope exist, and if so
to what extent, it is necessary to estimate a multiproduct cost
function.  Moreover, the functional form must yield plausible estimates
of the costs that would obtain if only one product were produced at any
one time.  In principle this is straightforward.  Eq (1)  might, for
example, be generalized to a multiproduct setting by treating y as a
vector rather than a scalar.  In practice cost functions are often
specified in a way that prejudges the issue of economies of scope.
Suppose, for example, that the estimated cost function involves cost per
case expressed as a linear function of a casemix vector' 2
(9)  C/N =- 0 + Vjip,  + e,
where C/N is cost per admission and p,  is the proportion of cases
falling into the ith casemix category (there  being n categories
altogether).  Multiplying through by N gives the total cost counterpart
of eq (9),  namely
". Cf.  Barer  (198Z),  who  obtained  a  negative  but  insignificant  coefficient  in  his  equations.
12. Such  an  equation  was  used  by  Feldstein  (1967).10
(10)  C =  + e-
where  TiPO+P,  for  i=T,...,n-1, =P and  e  =e*N.  It is  evident  that the
average  cost  function  (9)  implicitly  assumes  that  there  are  no economies
of scope,  because  overall  total  cost  is simply  the sum  of the
product-specific  total  costs.1
3
The  estimated  cost  function  must therefore  be sufficiently  general
to allow  for  either  or both of the  two  possible  sources  of economies  of
scope:  (1)  fixed  or quasi-fixed' 4 costs  that  are  not  product-specific
and, (2)  cost  complementarities.  Suppose,  for  example,  that  treating
the  various  inpatient  categories  requires  use  of some central  facility,
and  that  the  associated  cost  is invariant  with respect  to the hospital's
level  of activity. Then  eq (10)  would  include  a constant  term (which
may or  may not  become  zero  when all  outputs  fall  to zero)  and  Sc  would
become  positive. If,  by contrast,  each  product  line  simply  had  its  own
quasi-fixed  costs  which  could  be avoided  by ceasing  production  of the
product  in question,  fixed  costs  would  not  generate  any  economies  of
scope. The  alternative  source  of economies  of scope  is cost
complementarities:  a situation  where  the  marginal  cost  of one  product  is
a  decreasing  function  of the  amount  being  produced  of other  products.
This is  evidently  not  the  case in  eq (10),  because  the  marginal  cost  of
casetype  i is Ti,  which  is a constant. To allow  for  cost
complementarities  the  cost  function  would  need  to include  interaction
terms  between  the  various  outputs.
2.4  Too  many  hospitals?
A further  important  issue  AC
facing  policy-makers  in
developed  and  developing
countries  alike  is  whether  the
current  number  of hospitals
should  be increased  or reduced
to cope  with the  existing
workload.
In  the case  of a
single-product  industry  with  a
U-shaped  average  cost  curve  it  Im  y
is  straightforward  to  determine
the  cost-minimizing  number  of  Figure 4
producers  for  the  industry  in
question.  If  y'  is  industry
13.  This  conclusion  is  unaffected  by  the  inclusion  of  variabLes  such  as  the  stock  of  beds  and  casefLow  in
eq  (9).
t4.  By "squasi-fixed  costs"  we  mean  costs  that  do  not  vary  with  the  level  of  output  but  which  are  only
incurred  if  production  is  positive  Ecf  Baumol  and  Witlig  (1981)].11
output, and if ym is  the minimum point of the average cost curve (cf fig
4), the cost-minimizing number of producers, m,  is equal to y'/ym
(Baumol et al. (1982; 23)).  If this is not an integer, m*  is either the
integer just below yl/y m or the integer just above it.  The intuition is
straightforward.  Suppose that y'=ym. Then getting two firms to produce
½yl  each would cost more than getting one to produce the whole amount by
itself.
Evidently when y'  is sufficiently large relative to ym, each
producer will, in the cost-minimizing industry structure, operate at the
minimum point of its average cost curve.  Hence the interest in the
hospital cost literature in economies of scale.  In the single-product
case these are measured by the elasticity of total cost with respect to
output:
6  = (6C/C)/(6y/y) = (6C/6y).y (1/C)  = 6lnC/6lny,
which is equal to the ratio of marginal cost to average cost.  If
economies of scale exist, 6<1  and average cost is falling, while e>1
implies diseconomies of scale and a rising average cost.  It is
customary to measure economies of scale using the reciprocal of e: thus
(11)  S =  AC/MC = C /  (6C/6y)-y  = 1/(6lnC/5lny),
which is positive if economies of scale exist and negative if
diseconomies of scale exist.
In the light of the result above concerning the optimal number of
producers, and the definition of S, it is understandable that authors
whose results point towards the existence of economies of scale conclude
that too many hospitals exist, while those whose results point towards
diseconomies of scale conclude that too few hospitals exist."
5 There
is, however, a complication that needs to be borne in mind that is often
overlooked, namely that the issue of whether there are too few or too
many hospitals is necessarily a long-run problem and hence economies of
scale should be evaluated in the context of the long-run, as is
envisaged in the traditional textbook definition of economies of scale.
Thus in eq (11)  AC should be interpreted as long-run average cost and MC
as long-run marginal cost.
Because of this, it is tempting to try to estimate a long-run cost
curve directly.  It is often assumed that this can be achieved simply by
omitting capital from the cost function (cf  eg Granneman et al. (1986)].
The problem with this approach is obvious: only in the rather unlikely
event that hospitals have adjusted their capital stock to its long-run
equilibrium value will a hospital be operating on its long-run cost
'r.  Although  this  conclusion  is  sound  when  9 is  large  reLative  to  Yi,  it  is  evident  that  when  y'  is  small
relative  to  ym,  it  may  welt  be  optimal  for  a  small  number  of  producers  to  be  producing  to  the  left  or  right  of
Ym.  The  presence  of  economies  or  diseconomies  of  scale  is  not  necessarily  indicative  therefore  of  there  being
too  many  or  too  few  hospitals.12
curve.  If hospitals have not adjusted their capital stocks to the
long-run optimal level, their actual average costs will exceed LAC and
their actual marginal costs will differ from LMC.  Attempting to
estimate a long-run equation in this context will yield unreliable
estimates of LMC and LAC and hence of S.
Some authors have instead sought to infer economies of scale from
the variable cost function Cv(y,wv,K).  Cowing and Holtmann (1983), for
example, compute S as the reciprocal of 6lnCv/6lny.  As Vita (1990)
notes, this does not in fact capture economies of scale.  Eq (2) above
can be solved to obtain the long-run equilibrium level of capital
(12)  K  - K*(y,wK,wv),
which can then be substituted into (1) to obtain the long-run cost curve
(13)  C(y,wK,wv)  =  WKK  (Y,WK,Wv)  + Cv(Y,Wv,kX(y,WK,Wv)).
The partial derivative 6Cv/6y is equal to short-run marginal cost, while
what is required is the total derivative of total cost with respect to
y.  The latter, unlike the former, takes into account the effects of
output changes on the optimal capital stock and the effects of these
changes in capital on fixed and variable costs.  What the derivative
6lnCv/6lny  does show is whether a hospital has exploited all possible
returns to the variable input(s) and therefore whether the hospital is
operating to the left or right of the minimum point of its short-run
average cost curve.  This may be of some interest in its own right, but
it does not bear on the issue of economies of scale.
It is possible, however, to draw inferences about economies of
scale from a variable cost curve by invoking the envelope condition.  As
is reported in, for example, Braeutigam and Daughety  (1983),  S can be
computed as
(11')  Sv  =  (l-6lnCv/6lnK)/(6lnCv/6lny).
In this formula the derivatives ought in principle to be evaluated at K'
(cf Friedlaender and Spady (1981)].  In his analysis of American
hospitals Vita (1990) does not have access to the price of the fixed
input and hence cannot compute K*;  he therefore evaluates the
derivatives at the actual value of K, an approach suggested by Caves et
al. (1981).  This, like the approach of Cowing and Holtmann, hinges on
the assumption that the dependent variable in the cost equation is
indeed Cv.  If, as suggested above, the reported costs include some
element of fixed costs, one's inferences concerning economies of scale
will be unreliable.  An alternative would be to estimate a short-run
total cost equation, which is additive in fixed and variable costs, and
then compute Sv using eq (11') and differentiating that part of the cost
function that captures variable costs, or compute S using eq (11) and
bearing in mind that K* depends on y (cf eq (13)].13
Thus far we have assumed
that hospitals produce just one  c
product.  Yet as the discussion
above of economies of scope
makes clear, such an assumption
is unwarranted.  This raises
the issue of what determines  PAC
the cost-minimizing number of
hospitals in a multi-product
context.  The appropriate cost  R
concept in such a situation is
ray average costs (RAC).  Along
the ray R in fig 5 the output
mix is unchanged.  The RAC at
each  point  on  this  ray  is  equal
to the slope of the chord drawn  Figure 5
from the origin to the total
cost surface above the ray.  In
the case illustrated, RAC
reaches its minimum at ym on the ray R.  Evidently for each such ray
there exists a different RAC curve and hence, assuming each is U-shaped
as in fig 5, a different output combination at which the RAC reaches its
minimum.
The locus of such output
combinations is shown in fig 6
and is termed the M locus  y  locu
(Baumol  et  al.  (1982)].  Let  y'
be the current output vector on
ray R  and let t y'  be the
output level at which the RAC
for  ray  R reaches  its minimum  tyi  Y  R
point.  Given the logic of the  \
single-product case, one might
expect the cost-minimizing
number of producers in the
multi-product case to be equal
to l/t if this an integer, or  y
to the integer just below or
just above l/t.  Thus if RPP  Figure 6
reaches its minimum at one
tenth of industry output, one
might reasonably expect the
cost-minimizing number of producers to be equal to 10.  As Baumol et al.
(op cit) show, however, this is not necessarily the case.  The lower and
upper bounds that can be derived for the cost-minimizing number of
producers are, it turns out, relatively wide.  Moreover, their
calculation requires information on the location of ym  for output mixes
other than the current mix.
In these calculations the shape of the RAC surface is crucial,
though the relationship between this and the optimal number of producers14
is far from straightforward.  Empirically the output mixes at which the
RACs reach a minimum can be investigated using the multi-product
analogue of economies of scale, ray economies of scale, defined as
(14)  SN =  C  /  2;(6C/6y 1 ).y 1 =  1/E;#
where El  is the elasticity of cost with respect to output i.  Ray
economies (diseconomies) are said to exist if SN is greater  (less) than
unity.  Since SN can be shown to be equal to the reciprocal of one plus
the elasticity of RAC(t-y) with respect to t, it follows that ray
economies (diseconomies) of scale imply that RAC is decreasing
(increasing) [cf Baumol et al. (1982)].  As in the single product case,
the formula for economies of scale needs to be modified if a variable
cost equation or a short-run total cost equation has been estimated.  In
the case of the former the appropriate formula for SN is
(14')  SN =  (1-6lnCv/6lnK))/SiE 1,
which ought to be evaluated at K*,  while in the case of  the latter one
can proceed using either of the approaches suggested above for the
single product case.
The extent of any ray economies of scale can be shown to depend in
part on economies of scope and in part on Product-specific economies of
scale.  The latter indicate what happens to cost when one alters the
level of production of one product, holding the other output levels
constant.  The incremental cost of product 1 in the two-product case is
defined as
(15)  ICI  =  (C(y,,y 2)-C(O,y 2)],
which indicates the addition to the producer's costs resulting from the
current level of output of product 1.  The averace incremental cost of
producing y,  is then defined as
(16)  AIC,  =  IC,/y,
and indicates the extra cost associated with producing product 1
averaged over the amount of y,  produced.  Product-specific economies of
scale in the production of product 1 are then measured as
(17)  S,  =  AIC,/MC,,
where, as before, an index value that is greater (less) than one
indicates economies (diseconomies) of snale.  It can be shown [cf  eg
Baumol et al. (op cit)] that
(18)  SN =  [WSI +  (1-W)S 2j  /  (-SC),
where w=y,MC,/[y,MC,+y 2 MC 2J.  Thus if economies of scope are sufficiently
strong, ray economies can exist even if there are no product-specific
economies.  Indeed, sufficiently strong economies of scope might15
generate ray economies of scale even in the presence of product-specific
diseconomies.  Conversely, sufficiently strong diseconomies of scope
might result in ray diseconomies of scale even if product-specific
economies of scale exist.  Evidently, since product-specific economies
of scale, like ray economies of scale, are a long-run concept, AIC and
MC ought to be evaluated using a long-run cost function.
3. Hospital costs in Kenya
Anderson  (1980) reports the results of a cost function estimated
on data for 51 provincial and district public hospitals in Kenya in
1975/76.  His estimating equation takes the form
(19)  ln(C/I) =  ao  +  a,lnB  +  a2lnR +  a3lnS  +  a4ln(OUTP/I)  .+  a5lnSAT +
a 6PROV  +  v,
where C is total cost, B is the stock of beds, R is the occupancy rate,
I is inpatient days, S is mean length of stay,  OUTP is outpatient
visits, SAT is the number of associated sub-hospital facilities, PROV is
a  dummy taking a value of one if the hospital is a provincial hospital
and zero if it is a district hospital and v is an error term.  If we
substitute R=I/(365-B) and S=I/A, where A is admissions, eq (19) can be
rearranged as a total cost function of the form
(19') lnC =  aO  +  (a,-a 3)lnB +  (l+a2+a3-a4)lnI  - a3lnA  +  a4lnOUTP  +  a5lnSAT  +
a 6PROV  +  v.
The  equation  estimated  (eq  19)  Table  1:  Parameter  Estimates  of
implies  an  elasticity  of  cost  with  Anderson's  Equation
respect  to  inpatient  days  of  one  A
minus  the  elasticity  of  cost  with  Variable  Parameter  Value
respect  to  outpatient  visits  if
occupancy rate and length of stay  Constant  a 0 6.57
are not allowed to change.  The  inB  a,  -0.20
total  cost  form  allows  R and  S  to
change, but the interrelationship  InR  a 2 -0.44
of the  coefficients  in the  total  InS  a.  -0.07
cost form remains, of course,
entirely the artifact of the  ln(OUTP/1)  04  0.29
equation estimated.  Note too that  InSAT  a.  0.19
this Cobb-Douglas-type cost
function implies that if either  PROV  a°  0.28
output is zero, cost is
automatically zero, which is
consist  '  with the equation being  Adjusted  R 2 0.75
interpreted  as  a  variable  cost  Note:  Dependent  variable  is ln(C/I).
equation.  Anderson's  estimates  of  Parameters  taken  from  column  labelled  R-
the  parameters  of  eq  (19)  are  4 of  Anderson's  table  1.
shown  in  table  1.16
3.1 Are Kenvan hospitals over-capitaiized?
The negative coefficient on beds in Anderson's study, coupled with
the lack of fixed costs in the equation, suggests that the estimated
equation can indeed be interpreted as a variable cost equation.  Hence
the Cowing-Holtmann test for over-capitalization would be applicable.
Notwithstanding Anderson's claims to the contrary, the negative
coefficient does not of itself imply under-capitalization.  Only if
6Cv/6K is less than -wK can one conclude that "cost savings could be
obtained by expanding existing facilities" (Anderson (op cit, p233)].
Since Anderson does not report an estimate of wK,  or the mean values of
Cv and K, one cannot establish from his paper whether Kenyan hospitals
are indeed under-capitalized.
3.2 Inefficiency in Kenvan hospitals
Although Anderson does not explicitly address the issue of
efficiency, it might be argued that he does so implicitly by including
several variables that are not required by economic theory.  One problem
with this line of argument is, of course, that it is difficult in the
context of the hospital sector to determine whether a variable is an
'additional' variable, or whether it is included in attempt to capture
better inter-hospital variations in output.  Anoth-r problem is that, as
emphasized above, no account is taken in this non-frontier approach of
the fact that inefficiency is cost-increasing.
In the Kenyan study four variables are potentially  'additional'
variables:  the occupancy rate, length of stay, the number of associated
hospital sub-facilities, and the province/district dummy.  Inclusion of
occupancy rate cannot be rationalized in terms of its being a proxy for
output.  The implication of the results in table 1 are that hospitals
with low occupancy rates are inefficient.  It is also hard to justify
viewing length of stay as an output proxy, given that inpatient days are
used as the output measure for inpatient care and these already reflect
length of stay.  The relevant coefficient is not, however, significant.
Whether variations in the number of associated hospital sub-facilities
reflects output variations is unclear.  The province/district dummy
probably does reflect - at least in part - differences in output, since
it is likely that provincial hospitals end up treating more complicated
cases.  This may explain at least partly the positive and significant
coefficient on the province/district dummy.
3.3 Economies of scope in Kenyan hospitals
The Cobb-Douglas functional form adopted by Anderson implies that
costs fall to zero whenever the production level of either output falls
to zero.  As Baumol et al. (1982:449) note, this implies that industry
costs can (ostensibly) be driven to zero by dividing outputs among
specialized producers.  The Cobb-Douglas specification automatically
gives rise to cost anti-complementarities if the cost elasticities are
positive (as they are in the present case) and hence (in the absence of
fixed costs) results in diseconomies of scope.  The Cobb-Douglas cost17
function is thus insufficiently flexible to test for economies of scope
in a multiproduct environment.
3.4 Too many hospitals in Kenya?
Ignoring for the moment the long-run nature of economies of scale,
in the case of eq (19')  we have
S=  1 +  a 2 +  C3  - C4  0.2
and
SOUM =  a4 =  0.3
so that both outputs have product-specific diseconomies of scale.  Given
the result in eq (18) above, we would expect ray economies of scale to
exist if these product-specific economies are sufficiently strong to
offset the assumed diseconomies of scope.  In fact
SN =  1  /  (1  +  a2 +  a3 )  =  2.0.
This does not takes into account that the estimated equation is
not a long-run equation, but rather a variable cost function.  Because
of this it is more appropriate to compute SN using eq (14')  rather than
eq (14).  Ideally 6lnCv/6lnK  would be evaluated at K,  but since there
is insufficient information in Anderson's paper to calculate KX,  we
evaluate  SN  at the actual value of K.  This gives
SN  =  (1-a, + a 2)/(a 4 +  (1  +  a2 +  a3 - a4)  =  1.55,
implying mild ray economies of scale.'' 6 The implication is that the ray
average cost curve is downward sloping and that product-specific
economies of scale are also larger than the short-run estimates above
suggest.  However, as indicated above, the fact that ray economies exist
in a multiproduct setting does not necessarily mean that there ought to
be fewer hospitals.  Moreover, given the restrictions in the estimated
equation, the fact that SN points towards ray economies of scale ought
to be treated with some caution.
4.  Hospital costs in Peru
Dor (1987) reports the results of a cost function estimated on
data for 19 urban public hospitals in Peru in 1984.  His equation bears
a close resemblance to the equations estimated by Feldstein (1967) and
takes the form
(20)  C/A  =  ao  +  a,F  +  a2F 2 +  a3OUTP  +  a4%DEL  +  a5%SURG  +  adMIN  +  v,
l.  Anderson  also  concluded  that  hospitals  in  his  sample  exhibited  economies  of  scale.  However,  his
conclusions  were  based  on  the  value  of  the  coefficient  on  the  stock  of  beds,  which,  as  we  argued  above,  bears
on the Issue  of over-capitalization  rather  than  economies  of scale.18
where  A is the  number  of admissions,  %DEL is  the  proportion  of
admissions  taken  up by deliveries,  %SURG  is the  proportion  of cases
receiving  surgery  and  MIN is a dummy  taking  value  of one if the  hospital
is under  the  control  of the  ministry. Eq (20)  implies  a total  cost
function  of the form
(20') C =  aoA  +  axA-F  +  a2gA-F 2 +  a3A-OUTP +  a4DEL +  asSURG  +  aX6AMIN  +  v,
where  DEL is the  number  of deliveries,  SURG  is  the  number  of  Table 2:  Parameter  Estimates  of Dor's deliveries,  SURG is  the  number  of  Equation
inpatients  admitted  for  surgery
and  v=A*v.  It  is  evident  that  if  Variable  Parameter  Value
admissions  are  zero,  total  cost is
zero, irrespective of whether any  Constant  aO  12076.94
outpatients  are  being  seen  or not.  F  a  -6168.90
This,  coupled  with  the fact  that
the stock  of beds  does  not  appear  F 2 a2  961.16
as a regressor  in the  estimating  OUTP  as  0.003
equation,  suggests  that  eq (20')
is probably  best interpreted  as a  %DELIV  04  802.30
long-run  total  cost  function.  %SURG  a-  562.45
Dor's  parameter  estimates  are
shown  in  table  2.  MIN  as  -1635.38
4.1  Are  Peruvian  hospitals
over-capitalized?  Adjusted  R2 0.98
Note:  Dependent  variable is cost per
Since  Dor' s  esti.mating  admission. Weighted  Least Squares
equation  is  a  long-run  equation,  estimates  taken from column  (2.9) of
it  is  assumed  implicitly  that  the  Dor's  table  2.
stock  of  capital  is  at  its
long-run  optimal  value. No test
for  over-capitalization  is  therefore  possible.
4.2 Inefficiency  in Peruvian  hospitals
Like  Anderson,  Dor  does  not  analyze  efficiency  explicitly  but
might  be said  to do so implicitly  by including  various  'non-traditional'
variables  in his  cost  function. Clearly  one  would  not  include  among
these  the  outpatient  variable  and  the  two  casemix  variables,  which
reflect  output. This leaves  three  variables  that  might  be argued  to be
'additional':  the affiliation  dummy,  caseflow  and its  square. Whether
the  affiliation  dummy  (which  takes  a value  of one if  the hospital  is
operated  by the  Ministry  of Health  and  zero  if operated  by the social
security  system)  might  capture  output  variations  is  unclear. If it does
not,  the  results  in table  2 suggest  that  hospitals  operated  by the
Ministry  of Health  are  more  efficient. Turning  to the  effects  of
caseflow,  it is  evident  that  the  partial  relationship  between  average
cost  and caseflow  is  U-shaped,  reaching  a minimum  at 3.2  cases  per  bed
per  month,  which  is above  the  sample  average  of 2.8.  The inference
drawn  by Dor is that  most  hospitals  have  unnecessarily  high  costs19
because their caseflows are too low.  Much the same conclusion was
reached by Feldstein (1967),  who found that the  'inefficient' hospitals
with the below-average caseflows tended to be the larger hospitals and
tended to have low caseflows because of above-averag& lengths of stay.
Several writers have, however, questioned Feldstein's conclusion: it may
well be that larger hospitals may have an above-average mean length of
stay and hence a below-average caseflow because they treat the more
severe cases (cf  Barlow (1968), Fuchs (1969),  Lave and Lave (1970)3.
The same note of caution would seem appropriate in the context of Dor's
study, if low caseflows are due to long lengths of stay rather than to
low occupancy rates.
4.3 Economies of scope in Peruvian hospitals
Dor has, in effect, four outputs in his equation: deliveries,
surgical procedures, other inpatient care, and outpatient visits.
Denoting by OTH non-surgery and non-delivery admissions, eq (20')
becomes
(21)  C =  (aO+a 4)DEL  +  a1F-DEL +  a2F2DEL +  a3DEL-OUTP  +  a6DEL-MIN
+  (aO+a 5)SURG  +  a,F-SURG  +  a2F2,SURG +  a3SYJRG-OUTP  +  a6SURG-MIN +
+  aoOTH  + a,F'OTH  + a2F 2.OTH + a3OTH'OUTP  + a6OTH*MIN  + v-,
Overall economies of scope can then be calculated as
SC =  [C(DEL,O,O,0)+C(O,SURG,0,0)+C(O,O,OTH,O)+C(O,O,O,OUTP)
-C(DEL,SURG,OTH,OUTP)]/C(DEL,SURG,OTH,OUTP),
which, in this case, turns out to be equal to
Sc =  -a3(DEL+SURG+OTH)-OUTP /  C(DEL,SURG,OTH,OUTP).
Since the estimate of a3 is positive, Sc<O  and there are therefore
diseconomies of scope.  From the point of view of economies of scope,
however, Dor's specification is highly restrictive.  Given that A and
OUTP are both positive, the sign of Sc  depends entirely on the sign of
a 3. But since A is positive, a 3 is also the sole determinant of the sign
of the marginal cost of an outpatient visit (ie a3A).  Given that a
negative marginal cost is implausible, Dor's specification in effect
constrains Sc  to being negative.  As in Anderson's study, therefore, the
issue of economies of scope is prejudged by the model specification.
4.4 Too many hospitals in Peru?
Since eq (21) is to be interpreted as a long-run equation,
economies of scale can be inferred directly from it.  It is apparent
from eq (21)  that the average incremental cost and marginal cost of each
output are by construction equal to one another.  Hence the value of the
product-specific economies-of-scale index S,  is by construction equal to20
one for all outputs.  Thus Dor's specification prejudges the issue of
product-specific economies of scale, as well as the issue of economies
of scope.  Given the relationship between these two concepts and the
concept of ray economies of scale, it is clear that Dor's specification
must also prejudge the latter issue.  Substituting the marginal costs of
the four outputs into eq (14)  yields
SN - C  /  1C + a3(DEL+SURG+OTH).OUTP],
which is less than unity, given a3>0.  The implication is that there are
ray diseconomies of scale in the Peruvian sample.  This result is, of
course, prejudged by the model specification.  Only in the implausible
case where the marginal cost of an outpatient visit is negative can SN
be larger than one.  Since the weights in the multiproduct analogue of
eq (18) sum to one, the relationship between ray economies of scale and
economies of scope in this case is
SN  I1  /  (l-SC)  I
which, given the expression for Sc  derived above, confirms the earlier
expression for SN.  Thus, because product-specific economies are ruled
out by assumption, it is the diseconomies of scope that give rise to the
ray diseconomies of scale.  But since the specification is compatible
only with diseconomies of scope, this finding is uninteresting.
5. Hospital costs in Ethiopia
Bitran and Dunlop (1989) report estimates of a cost function
estimated from an unbalanced panel of 38 observations on 15 public
hospitals in Ethiopia in the mid-1980s.  Their estimating equation is
similar to that of Granneman et al. (1986),  except that the stock of
beds is included and there are no cubic terms.  Their equation is of the
form
(22)  lnC  =  o +  a,B  +  PII  + pI2+  +I30UTP  +  P4OUTP 2 +  P5I-OUTP +
j6DELIV  +  0 7 SURG +  P8LAB +  v,
where  LAB  is the number of lab  tests  and  the  other  variables  are  as
defined  above.  The  parameter  estimates  of  eq (22)  are  shown  in  table  3.
5.1  Are  Ethiopian  hospitals  over-ca2italized?
The positive estimate of al  suggests  that  the  equation  estimated
by Bitran and Dunlop is not a variable cost equation but rather a
short-run total cost function.  The Cowing-Holtmann test for
over-capitalization would therefore seem to be inappropriate and points
towards the use of the alternative Feldstein-type test proposed above.
The fact that 6Cs/6K>O  in this study implies that hospitals in the
sample are too large, given their current output levels.  One ought,
however, to be wary about taking this conclusion at face value.  The
estimating equation does not satisfy the restrictions required of a21
short-run  total  cost  function:a  it
ishnort-run  additiveln  £  d  fction:  i  Table 3:  Parameter  Estimates of Bitran and is  not  additive  in  fixed  costs  and  Dunlop's Equation
variable  costs,  and  variable  costs
are  not  a  decreasing  function  of  Variable  Parameter  Value
the  stock  of  capital.  Constant  5.45
5.2  Inefficiency  i-n  B  01  4.71E-3
Ethiocian hosoitals
I  Rl  ~~~~~2.18E-5
Bitran  and  Dunlop  do  not  12  a 2 -1.65E-12
analyze efficiency explicitly.
Nor do they include any  OUTP  3  1.91E-6
'non-traditional'  variables in  OUTP
2 a 4 1.42E-10
their cost function which might be
said to capture inefficiency  I*OUTP  5  -7.50E-10
implicitly.  DELIV  6  1.68E-4
5.3  Economies of scope in  SURG  6 7 3.21 E-6
EthioDian  hospitals  LAB  a 8 7.63E-6
Bitran and Dunlop have, in
effect, five different outputs in  Adjusted  R2 0.96
their cost function: inpatient
days,  outpatient  visits,  Note:  Dependent  variable is InC.
deliveries, surgical procedures
and lab tests.  In calculating the economies of scope associated with eq
(22) it is important to be clear about which fixed costs would be
incurred and which would avoided in each scenario.  An extreme and
clearly implausible assumption would be that all outputs would, if
produced alone, require the same level of beds as at present.  In this
case projected stand-alone production costs are those indicated in
column 1 of table 4.  The projected costs incurred by the average
hospital at present are 1006231 Birr (Bitran  and Dunlop (op cit, table
A.3)).  The overall degree of economies of scope are therefore
Sc  =  (3155873-10062313/1006231  =  2.136,
which implies economies of scope.  If, instead, one assumes that
producing outpatient visits and lab tests alone would not necessitate
any beds, the stand-alone production costs are those indicated in column
2 of table 4 and the implied degree of economies of scope is equal to
Sc  =  (2527777-10062313/1006231  =  1.512,
which, unsurprisingly, is smaller than in the previous case.  But even
this probably overstates the true degree of economies of scope, the
reason being that the production of each of the inpatient outputs alone
is unlikely to require the full amount of beds currently being used.
This highlights a weakness of the specification used by Bitran and
Dunlop, namely that unlike the flexible fixed cost functional form
proposed by Baumol et al. (op  cit), it does not allow for the22
possibility that each production 'line'  has its own quasi-fixed costs
that are avoided if the production of that output ceases.
5.4  Too many hospitals in Ethiopia?
Suppose we ignore for the moment the long-run nature of economies
of scale and calculate ray economies of scale using eq (14).  The cost
elasticity of output i is equal to (6lnC/6y 1)y 1. If these are evaluated
at the means given in appendix 1 of Bitran and Dunlop, the cost
elasticities obtained are those indicated in table 4.  The large and
negative cost elasticity of outpatient visits suggests a serious model
misspecification and therefore the results below ought to be treated
with caution.  The elasticities imply that
SN =  1  /  0.296  =  3.38,
and hence imply substantial ray economies of scale.  This is despite the
fact that none of the outputs with positive marginal costs are
characterized by product-specific economies of scale (cf  table 4].  The
implication is that the ray economies of scale exist despite these
product-specific diseconomies and are to be attributed to the economies
of  scope noted earlier.
The ray economies uncovered above ignore the fact that the
equation estimated is not a long-run equation.  Nor apparently is it a
variable cost function.  One cannot therefore treat the derivative of
the cost function with respect to beds as reflecting 6lnCv/6lnK and use
eq (14), as was done above in the discussion of Anderson's results.
Moreover, since the estimated equation is not additive in fixed and
variable costs, one cannot recover 6lnCv/6lnK  from the estimated
equation.  Nor, given the lack of additivity, would it make sense to try
to solve for K',  even if information on the shadow price of beds were
reported in the study, which it is not.  The upshot of this is the
results in table 3 cannot be used to infer the true extent of ray
economies of scale.
6. Health care costs in Nigeria
Wouters  (1990)  reports the results of a cost function estimated on
24 Nigerian health care institutions, of which eight are health centers,
seven are maternity units and nine are dispensaries.  Her estimating
equation  is  of  the  form
(23)  lnC  =  ao  + aolnA  + a2lnOUTP  + a3ln(%DRUGS)  + a 4lnwHw +  a5lnwNHW  +
a6DBms  + a7DBE-lnB + a8lnAI  + v,
where  C is total cost, %DRUGS is the percentage of drugs available, wHw
and wNHW are the wages of health workers and non-health workers
respectively,  DBED  is  a  dummy  taking  a value of one if the facility has
beds  and  AI is  an  index  of  allocative  inefficiency  calculated  fromTable 4:  Economics of scope and scale-Bitran-Dunlop  study
Output  Cost of each output alone  MC  Cost  AIC  S  y  yOMC
Elasticity
With AN Beds  Only IP beds
Inpatient days  883532  883532  2.582  0.073  2.534  0.981  28410  73361
Outpatient visits  548476  268063  -12.226  40.310  -19.542  n.a.  25520  -311995
Deliveries  564877  231544  169.047  0.171  155.407  0.919  1016  171752
Surgical procedures  478934  478934  3.230  0.006  3.221  0.997  1758  5678
Lab tests  680054  332371  7.678  0.356  6.459  0.841  46691  358472
Sum  3155873  2527777  0.295  297268
Projected cobt of avg. beds  1006231
Economies  of scope (all beds)  2.136
Econs. of scope (only IP  beds)  1.512
Ray econs of scale (SR)  3.385
Elasticity of cost wrt  beds  0.716
Ray economies  of scale (LR)  0.96224
estimates of a production function (see section 2.2 above).' 7 Like
Anderson's equation, this Cobb-Douglas type equatior implies that cost
is zero if either output is zero.
6.1 Are Nigerian health care institutions over-capitalized?
The positive estimates of a6 and a7 suggests that Wouters'
equation, notwithstanding her claims to the contrary, is best
interpreted as a short-run total cost function rather than as a variable
cost equation.  As in the Ethiopia study, these positive coefficients
imply over-capitalization.  But once again one ought to be wary about
taking this conclusion at face value, since the estimating equation does
not satisfy the restrictions required of a short-run total cost
function.
6.2 Inefficiency in Nigerian health care institutions
Of the four studies included in this survey, Wouters' is the only
one which analyses efficiency explicitly.  She explores both technical
and allocative inefficiency.  Her method differs slightly from that
outlined  in  section  2.2 above.  Rather than estimating a SFM, she first
divides  her  sample  into  efficient
and  inefficient  facilities  on  the  Table 5:  Parameter  Estimates  of Wouters's
basis  of  the  number  of  visits  per  EquatiOn
health  worker  per  year  and  then  Variable  Parameter  Value
estimates  a  conventional
Cobb-Douglas  production  function  Constant  a 0 1.63
on the 'efficient' subsample.  The  InA  al  0.01
shortcomings of this approach are
obvious: it is arbitrary and fails  InOUTP  a2 0.60
to provide any evidence on  In(%DRUGS)  a3 -1.36
variation in technical
inefficiency within each group.  InwHw  4  0.59
Nonetheless,  it  does  have  an  InwNHw  a5 0.39
advantage over the frontier
production  function  approach  in  DBEDS  ae  0.22
that  whereas  the  frontier  approach  D, 05.inB  a7 0.09
models technical efficiency simply
as a shift factor, Wouters'  InAl  a 8 -0.16
approach allows the shape of the
production function to differ
between 'efficient' and  Adjusted  R2  0.91
'inefficient'  facilities.  Note:  Dependent  variable is InC.
Moreover, it  is  interesting  to
note that almost all of the
private facilities in Wcouters'  sample fall below the relatively generous
cutoff point for inclusion in the 'efficient' subsample.
".  Because of  zero values  admissions  and beds are,  in fact,  not entered  in  logarithms  but  are  instead
transformed  using the Box-Cox  metric (L=0.10). The  interpretation  of the coefficients  is much  the same  as for
variables expressed  in  logarithms.25
Wouters'  analysis  of allocative  inefficiency  is  more conventional.
From  her  estimates  of the  Cobb-Douglas  production  function  estimated  on
the 'efficient'  subsample,  she  finds  that  the  ratio  of the  marginal
product  of non-health  workers  to that of health  workers  is less  than  the
relevant  wage ratio,  implying  that non-health  workeri  are,  on average,
over-employed  relative  to health  workers. Allocative  inefficiency  is
then  measured  by AI in  eq (7). Interestingly,  the index  is smaller  in
value  in the  private  sector  than in  the  public  sector,  suggesting  that
at least  among  the  technically  efficient  facilities,  allocative
inefficiency  is lower  in  the  private  sector.' 8 Finally,  Wouters
includes  the log  of her inefficiency  index  in her  cost function  as a
regressor. Surprisingly,  its  coefficient  is negative  (though  not
significant),  implying  literally  that  allocative  inefficiency  reduces
costs.
6.3 Economies of scope in Nigerian health care institutions
Like  Anderson's  estimating  equation,  eq (23)  implies  that costs
fall  to zero  whenever  the  production  level  of either  output  falls  to
zero.  The specification  therefore  automatically  implies  diseconomies  of
scope  and an Sc  value  of -1.
6.4 Too many health care institutions in Nigeria?
Ignoring  for  the  moment  the long-run  nature  of economies  of scale,
eq  (14)  gives  a value  of SN equal to
SN =  1 /  a,+a 2 =  1.  645,
which  implies  ray  economies  exist. This  is despite  the fact  that,  as
noted above, Wouters' cost function automatically results in
diseconomies  of scope. The implication  is that  these  diseconomies  of
scope  are  offset  by sufficiently  strong  product-specific  economies  of
scale. This  is indeed  the  case.  From  Wouters'  estimating  equation  and
table  5  we obtain
SI  a15,  90.909
and
SOUrP= 1 /  a 2 =  1.675,
so that  both  outputs  enjoy  product-specific  economies  of scale. The
marginal  costs  of admissions  and  outpatient  visits  are  a,(C/A)  and
a2(C/OUTP)  respectively,  and  therefore  the  weights  in eq (18)  are
a,/(a,+a 2) and  a2/(a,+a 2) respectively.  Eq (18)  thus becomes
SN  =  (0.018-90.91  + 0.982-1.645] /  2 =  1.630,
l.  The  sample  size  is,  however,  very  smaLl,  the  number  of  private  facilities  being  onLy  3.26
which  is close  to the  value  of  SN obtained  above  and  confirms  that  the
product-specific  economies  of scale  more than  offset  the (assumed)
diseconomies  of scope.
These  estimated  ray  economies  ignore,  however,  the fact  that the
equation  estimated  is  not  a  long-run  equation  but  rather  a  short-run
total  cost  equation.  As in  the  case of Bitran-Dunlop  study  above,  this
means  that one  cannot  obtain  a true  measure  of ray  economies  of scale
from  the results  reported  in Wouters'  paper.
7. Conclusions
It is  evident  from  the  above,  and  not surprising  perhaps,  that
none  of the studies  of hospital  costs  in developing  countries  would
appear  to provide  reliable  evidence  on all  of the issues  of interest  to
policy-makers.
Although  the issue  of over-capitalization  is  clearly  important  in
its  own right,  it  also has  implications  for  the  investigation  of other
issues. Thus  even if  one's  interest  lies  with,  say,  economies  of scale,
the issue  of over-capitalization  cannot  be ignored,  since  if  hospitals
are  not in a long-run  equilibrium,  the estimated  parameters  will  not
provide  reliable  evidence  on economies  of scale. Estimating  a short-run
cost function,  irrespective  of whether  or not  one  is interested  in
over-capitalization,  which  is  the  practice  advocated  by Cowing,  Holtmann
and  Powers  (1983),  seems  eminently  sensible. It is therefore
unfortunate  that  Dor, in  his study  of hospital  costs  in Peru,  elected  to
estimate  a long-run  cost function. With regard  to testing  for
over-capitalization,  we have  argued  that since  in  practice  it is
difficult  to separate  fixed  costs  from  variable  costs,  the  test  proposed
by Cowing  and  Holtmann  (1983)  is unlikely  in  general  to be appropriate,
since  it  relies  on the  estimated  equation  being  a  variable  cost
function. Of the  three  short-run  cost  functions  included  in this
survey,  only in  Anderson's  was  the sign  of 6C/6K  consistent  with  the
equation  being  interpreted  as  a  variable  cost  equation.  But  although
the  Cowing-Holtmann  test  seems  valid  in  this case,  the  negative  value  of
6C/6K  and  the  absence  of information  on the shadow  price  of capital  make
testing  for  over-capitalization  impossible. In  the  case  of the  other
two studies,  where  the  positive  value  of 6C/6K  suggests  that  the
equation  estimated  is  a  short-run  total  cost  equation,  we  argued  that  a
more  appropriate  test  would  be  to test  whether  6C/6K=0. In  both  studies
6C/6K  was  positive,  which  interpreted  literally  implies
over-capitalization.  We argued,  however,  that  this conclusion  ought  not
to be taken  at face  value,  since  the  estimated  equations  are  not,  as
theory  requires,  additive  in fixed  and  variable  costs.
Of the studies  included  in  this survey,  only  Wouters'  analyses  the
issue  of efficiency  explicitly. Although  her  method  for investigating
technical  inefficiency  is somewhat  ad hoc  and  falls  short  of the
frontier  production  function  approach,  her approach  to allocative
inefficiency  is fairly  conventional.  She finds  evidence  in  her sample
of under-employment  of health  workers  relative  to non-health  workers,27
and that the degree of allocative inefficiency is greater in the private
sector.  Her finding that allocative inefficiency reduces costs must,
however, cast some doubt on these findings.  Since two of the other
studies include 'non-traditional'  variables in their cost function, it
might be argued that they too address the issue of inefficiency, albeit
implicitly.  The results of these studies suggest, for example, that low
occupancy rates are a sign of inefficiency, and that hospitals operated
by the Peruvian Ministry of Health are more efficient than those
operated by the Peruvian Social Security.  It is apparent from the above
that the large and growing econometric literature on efficiency
measurement has remained virtually untapped by the authors of hospital
cost functions in developing countries, as indeed is true of researchers
in industrialized countries.  Much more research could usefully be done
on this topic.
Of the four studies covered in the present survey only one employs
a specification that is sufficiently general not to prejudge the issue
of economies of scope.  Both Anderson and Wouters employ a multiproduct
Cobb-Douglas production, which, as Baumol et al. (1982) note, implicitly
assumes cost anti-complementarities and hence assumes diseconomies of
scope unless there are sufficiently strong offsetting fixed costs.
Dor's specification is less rigid but is consistent with economies of
scope only in the implausible case where the marginal cost of an
outpatient visit is negative.  Only in the Bitran-Dunlop study is the
model specification sufficiently general not to prejudge the issue of
economies of scope.  In the event the authors' results imply overall
economies of scope.  The extent of these economies is reduced, but are
still positive, if it is assumed, not unreasonably, that beds are
required only in the provision of inpatient services.  However, although
the Bitran-Dunlop specification is much less restrictive than the
specifications adopted in the other studies, it still has the
disadvantage that it does not take into account that each output may
have its own quasi-fixed costs.  Both of the aforementioned estimates of
the economies of scope index assume that if a hospital were to provide
no outpatient services and only one line of inpatient services (eg
deliveries), it would still require all the beds it currently uses, even
if the number of cases treated in the retained line were no greater than
the current number.  This is clearly unrealistic.  A more sensible
functional form is the flexible fixed cost function proposed by Baumol
et al. (1982), in which the quasi-fixed costs of each product line are
distinguished from one another. 19
Turning finally to economies of scale, we have seen that of the
three studies that prejudge the issue of economies of scope, two also
prejudge the issue of economies of scale.  In Anderson's specification
the cost elasticities sum to unity by construction.  Thus if one
calculates SN  using eq (14), the specification guarantees a value of SN
'O.  A  disadvantage  of  this  functional  form  is  that  the  separate  quasi-fixed  costs  are  identifiable  only
in  samptes  where  not  atl  producers  produce  all  outputs.28
of one.  If instead the equation is treated as a variable cost function
(which is consistent with the value of 6C/6K), the value of SN depends
solely on the value of 6lnC/6lnK.  Dor's specification also prejudges
the issue of ray economies of scale by implicitly assuming that the
product-specific economies-of-scale index Si  is equal to one for all
outputs.  Given this, the link between ray economies of scale, economies
of scope and product-specific economies of scale, and that the
specification in effect rules out economies of scope, it follows that
the specification forces ray diseconomies of scale.  Neither of the
remaining two studies prejudge the issue of ray economies of scale.
Bitran and Dunlop find slight product-specific diseconomies of scale
(although the negative marginal cost of one output suggests a model
misspecification) but find ray economies of scale.  The implication is
that these stem from the economies of scope noted above.  Wouters also
finds ray economies of scale but in contrast to Bitran and Dunlop finds
product-specific economies.  The economies-of-scale estimates of both
studies ought, however, to be treated with some caution, since these
results are calculated from equations which are probably best
interpreted  as  short-run  total  cost  equations,  albeit  equations  that  do
not  meet  the  theoretical  requirement  of  being  additive  in  fixed  and
variable costs.  At best the results indicate the effects of moving
along short-run cost curves.
We feel that it would be unwise to try to draw firm policy
conclusions from the four studies included in this survey.  In several
studies the issues being investigated are in effett prejudged by the
model specifications.  Where this is not the case, the model
specifications are often inconsistent with economic theory.  Some
authors claim, for example, to estimate a variable cost equation and yet
the parameter estimates are inconsistent with this interpretation.  Nor
are the specifications consistent with being interpreted as short-run
total cost functions, since the equations are not additive in fixed and
variable  costs.
We believe, however, that certain firm conclusions can be drawn
about the methodology of hospital cost function estimation.  These
conclusions would appear to be relevant to the estimation of hospital
costs functions in industrialized countries.  First, since hospitals may
well not be employing their long-run equilibrium quantities of capital,
it seems sensible to follow the line taken by Cowing et al. (1983) and
estimate a short-run cost function.  If capital is not wholly exogenous,
the obvious answer is to employ simultaneous equation techniques.  One
cannot, we believe, convincingly argue, as Granneman et al. (1986) seek
to, that the possible endogeneity of capital justifies the estimation of
a long-run equation.  Second, given the difficulty of purging fixed
costs from variable costs, it may be best to estimate a short-run total
cost equation, rather than a variable cost equation.  This ought to be
additive in fixed and variable costs, as required by economic theory,
and variable costs ought to be a decreasing function of the stock of29
capital.0  One can then test for  over-capitalization by testing to see
whether 6Cs/8K is positive.  Third, since hospitals may well be
technically and allocatively inefficient, and since cost frontier models
are relatively straightforward to estimate, it seems desirable that
greater use should be made of these models in future work in this area.
Disentangling technical and allocative inefficiency via a frontier
production function analysia also seems desirable.  Fourth, as the
studies in this survey indicate it is all too easy to specify a cost
function in a way that prejudges the issues that are of interest to
policy-makers.  Equations must be specified sufficiently flexibly to
allow the data rather than the model specification to indicate the
extent of any economies of scope, product-specific economies of scale,
and hence ray economies of scale.  Ideally these specifications would
allow one to determine the extent of any quasi-fixed costs associated
with each product line.  Finally, since economies of scale are a
long-run phenomenon, this needs to be borne in mind when calculating
their extent.  If a short-run cost function is estimated, this will
necessitate the calculation of the optimal capital stock, which will in
turn require data or estimates of the shadow price of capital.
. Barer's  (1982)  specification  meets  the  first  of  these  requirements  but  not  the  second.30
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